We're able to help take your European technology or life science start-up to the Chinese market - or, alternatively enter the European market for the first time. Whatever your stage of internationalisation, we're here to help make the journey easier with a greater likelihood of business success.
Take a look at a selection of FREE resources that will help make your biotechnology company global.
"While B2B start-ups are making Europe more competitive, start-ups, investors, and corporate will need to share expertise and work as partners to realize the region’s full entrepreneurial potential"
Download this article from McKinsey and Company to see and understand the European start-up landscape and how this will impact your technology or life science business .
The implementation of the new regulation to support the urgent clinical needs of medical device imports
- The product should be approved in US, Europe and/or Japan
- There are currently no other devices, serving the same purpose, which could be sourced from the Chinese market already
- The medical device can effectively provide clinical treatment or prevention to the patient with a life-threatening disease
- Significant clinical advantages of the device can be demonstrated
If you’re a medical device company treating life-threatening disease, Boao Hope City will be your ideal choice to enter the Chinese market. Entering the market this way, will lay a solid foundation for the local clinical studies which are needed later on for the NMPA approval. You'll also be able to offer your solution to patients who urgently need it.
In spite of COVID-19 the life science industry in China is still undergoing experiential growth. China has set new records in the new funds raised, VC investments, IPOs and partnering. This report, from the ChinaBio group provides an overview of 2020 and covers the opportunities available for your biotechnology start-up.